23-24 May 2023 | Dubai World Trade Centre

The leading event where knowledge and clinical adoption of precision medicine happens

A unique opportunity for exhibitors to showcase personalised medicine technology and services to buyers and partners from across healthcare.

2

World-Class Conferences

100

International Speakers

5,500

Targeted Visitors

CME

Accredited

100

Exhibitors

Dr. Khalid Fakhro, Chief Research Officer at Sidra Medicine and the Director of the healthcare facility’s Precision Medicine program delivering a keynote speech at PrecisionMed Expo 2022.

DISCOVER THE MIDDLE EAST’S PREMIER EXHIBITION AND SUMMIT DEVOTED EXCLUSIVELY TO PRECISION MEDICINE

Our second edition brings together a diverse line-up of over 100 international experts, knowledge leaders, and medical innovators to provide cutting-edge insights to drive healthcare from a one-size-fits-all model to a personalized, targeted approach.

PrecisionMed is running concurrently with the EMERGE 2050 investment forum, a thriving hub for pioneering health-tech startups to connect with potential investors.

Join us for an immersive, enlightening experience and gain competitive edge in the fast-evolving landscape of health tech.

CONFERENCE

Learn from 100+ thought leaders and industry experts who will dive deep into the new frontiers of precision medicine technologies, trends, digitisation and more.

EXHIBITION

Discover latest solutions across all areas of precision medicine from 30+ participating countries, including the UK, USA, Germany, and more!

NETWORKING & SIDE EVENTS

Make connections with influential professionals and practitioners in precision medicine to enhance your career, skills, and genome knowledge.

EMERGE 2050

At our co-located event, witness history in the making as aspiring health-tech startups deliver their pitches to source funding from ready investors.

The estimated precision medicine market valuation
by the year 2025 is about
$126 billion.
The compound annual growth rate of the market is predicted to be 12.48%.

*Source: Market Research Future

TAKING HEALTHCARE FROM “ONE SIZE FITS ALL” TO A TARGETED APPROACH

PMES 2023 provides a unique opportunity to listen to and network with key opinion leaders, international scientists, and key healthcare decision-makers.

  • Discover how developments from clinical research can be applied to improve patient outcomes.

  • Identify opportunities that integrate innovative treatment approaches into daily clinical practice and healthcare systems.
  • Uncover the latest advances in patient targeted precision medicine technology.
  • Learn how pharmacogenomics has identified the influence of genetic variation on patient drug responses.
  • Realise the importance of a personalised patient treatment plan.
  • Develop an appreciation for how artificial intelligence (AI), or machine learning, has driven a new paradigm in personalized medicine.
  • Hear how new codes of practice regulate data protection, patient privacy and data sharing allowing precision medicine to be implemented in real-world healthcare.

SCIENTIFIC COMMITTEE

Dr. Min S. Park
CSO, Sanimed International & Chair of the Scientific Committee

Dr. Mariam Matar
Founder and Chairperson, UAE Genetic Diseases Association (UAEGDA)

Dr. Ahmad Abou Tayoun
Director – Genetic Laboratory,
Al Jalila Children’s Hospital

Prof. Fatma Al Jasmi
Chair of Genetics & Genomics Department, UAE University College of Medicine & Health Science

Dr. Thomas Launey
VP Molecular Biotech & Genomics Biotechnology Research Center, Technical Innovation Institute

Dr. Julie Decock
Scientist, Qatar Biomedical Research Institute

Mohamed Nagy
Head of Personalized Medication Management Unit, Children’s Cancer Hospital, Egypt

Prof. George P. Patrinos
Professor and Head of Laboratory; Editor-in-Chief, The Pharmacogenomics Journal, University of Patras

Prof. Bassam Ali
Professor in Molecular and Genetic Medicine & Leader of the Genetics and Development Research, UAE University

precisionmed EXpo TO COVER TOPICS SUCH AS:

An Exclusive Interview with Dr. Byoung Kwon Kim

Meet Dr. Byoung Kwon Kim, Consultant Pathologist, Department of Pathology, Sheikh Khalifa Specialty Hospital (SKSH)

Dr. Kim is currently serving as a consultant pathologist at SKSH, UAE. He has diverse experiences encompassing public institutions, academia, and industry. In the past he has served as a researcher at the Armed Forces Hospital, a clinical professor at Seoul National University (SNU) and director of molecular pathology, Korea.

See the entire interview on our LinkedIn page.

2023 EXHIBITORS